B.R.A.I.N. Biotechnology Research and Information Network AG (“BRAIN AG”), Zwingenberg, successfully completed its IPO with the initial listing of its shares on the Frankfurt Stock Exchange on 9 February 2016. The total issue volume was €31.5m. A total of 3,500,000 shares resulting from a capital increase were placed in the context of the offering. In addition, the hitherto majority shareholder of the company made available 108,054 of its shares as part of an over-allotment option for market stabilisation reasons.

BRAIN is one of Europe’s leading technology companies in the field of industrial or “white” biotechnology.

Hengeler Mueller advised MP Beteiligungs-GmbH acting as majority shareholder on the IPO of BRAIN AG. The Hengeler Mueller team was led by partner Wolfgang Groß (Capital Markets) and Peter Weyland (Corporate) as well as associate Annika Clauss (Corporate) (all Frankfurt).

The original press release can be found here on Hengeler Mueller’s website.